Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A23900 | 23396728 | Ann Hepatol | S-adenosylmethionine metabolism and liver disease. | 2013 | Details |
| A23901 | 23395669 | Toxicol In Vitro | Sophocarpine alleviates hepatocyte steatosis through activating AMPK signaling pathway. | 2013 | Details |
| A23903 | 23394097 | Curr Pharm Des | Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment. | 2013 | Details |
| A23904 | 23394096 | Curr Pharm Des | Classical and innovative insulin sensitizing drugs for the prevention and treatment of NAFLD. | 2013 | Details |
| A23905 | 23394095 | Curr Pharm Des | The role of lifestyle change in the prevention and treatment of NAFLD. | 2013 | Details |
| A23906 | 23394094 | Curr Pharm Des | Antioxidant therapy and drugs interfering with lipid metabolism: could they be effective in NAFLD patients? | 2013 | Details |
| A23907 | 23394093 | Curr Pharm Des | From NAFLD to NASH and HCC: pathogenetic mechanisms and therapeutic insights. | 2013 | Details |
| A23908 | 23394092 | Curr Pharm Des | Pathophysiology of NASH: perspectives for a targeted treatment. | 2013 | Details |
| A23909 | 23394091 | Curr Pharm Des | Epidemiology and natural history of patients with NAFLD. | 2013 | Details |
| A23910 | 23394090 | Curr Pharm Des | Non invasive indexes for the assessment of patients with non-alcoholic fatty liver disease. | 2013 | Details |
| A23911 | 23392905 | Clin Chem Lab Med | Serum carcinoembryonic antigen is associated with non-alcoholic fatty liver disease in healthy Korean non-smokers. | 2013 | Details |
| A23912 | 23392740 | Pathologe | [Non-alcoholic steatohepatitis and cirrhosis in young adult patients with hypothalamic-pituitary dysfunction]. | 2013 | Details |
| A23913 | 23391869 | J Clin Gastroenterol | The severity of histologic liver lesions is independent of body mass index in patients with nonalcoholic fatty liver disease. | 2013 | Details |
| A23914 | 23391614 | Toxicol Appl Pharmacol | Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease. | 2013 | Details |
| A23915 | 23390894 | Atherosclerosis | The clinical availability of non alcoholic fatty liver disease as an early predictor of the metabolic syndrome in Korean men: 5-year's prospective cohort study. | 2013 | Details |
| A23916 | 23390892 | Atherosclerosis | Sex-influenced association of nonalcoholic fatty liver disease with coronary heart disease. | 2013 | Details |
| A23917 | 23390441 | Korean J Pediatr | The efficacy of aspartate aminotransferase-to-platelet ratio index for assessing hepatic fibrosis in childhood nonalcoholic steatohepatitis for medical practice. | 2013 | Details |
| A23918 | 23390127 | Hepatology | Dietary fructose in nonalcoholic fatty liver disease. | 2013 | Details |
| A23919 | 23390010 | Magn Reson Med | Cationized ferritin as a magnetic resonance imaging probe to detect microstructural changes in a rat model of non-alcoholic steatohepatitis. | 2013 | Details |
| A23920 | 23389749 | Food Funct | Hibiscus sabdariffa L. aqueous extract attenuates hepatic steatosis through down-regulation of PPAR-γ and SREBP-1c in diet-induced obese mice. | 2013 | Details |
| A23921 | 23388528 | Georgian Med News | [Fat distribution and its relationship with genetic polymorphism in patients with nonalcoholic liver disease]. | 2013 | Details |
| A23922 | 23387384 | Obes Rev | Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis. | 2013 | Details |
| A23923 | 23387211 | Sichuan Da Xue Xue Bao Yi Xue Ban | [Impact of electro-acupuncture on lipid metalolism in rats with non-alcoholic fatty liver disease]. | 2012 | Details |
| A23924 | 23385644 | J Mol Med (Berl) | Lack of kinin B₁ receptor potentiates leptin action in the liver. | 2013 | Details |
| A23925 | 23384548 | J Pharm Biomed Anal | Pharmacokinetic study of major bioactive components in rats after oral administration of extract of Ilex hainanensis by high-performance liquid chromatography/electrospray ionization mass spectrometry. | 2013 | Details |
| A23926 | 23383649 | Aliment Pharmacol Ther | Association between novel MRI-estimated pancreatic fat and liver histology-determined steatosis and fibrosis in non-alcoholic fatty liver disease. | 2013 | Details |
| A23927 | 23383521 | Acta Gastroenterol Latinoam | [Correlation between fatty infiltration of the liver and body mass index, triglycerides and transaminases]. | 2012 | Details |
| A23928 | 23382293 | Radiology | Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. | 2013 | Details |
| A23929 | 23382291 | Radiology | Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. | 2013 | Details |
| A23934 | 23375992 | Diabetes Res Clin Pract | Association of 11β-hydroxysteroid dehydrogenase type 1 gene polymorphisms with serum alanine aminotransferase activity. | 2013 | Details |
| A23935 | 23374505 | Hepatol Res | Derangement of ghrelin secretion after long-term high-fat diet feeding in rats. | 2013 | Details |
| A23936 | 23373292 | Vopr Kurortol Fizioter Lech Fiz Kult | [Balneotherapeutics of non-alcoholic fatty liver disease with the use of the Essentuki-type drinking mineral waters]. | 2013 | Details |
| A23937 | 23371785 | Plant Foods Hum Nutr | Oat prevents obesity and abdominal fat distribution, and improves liver function in humans. | 2013 | Details |
| A23938 | 23370710 | Transplantation | Evolving frequency and outcomes of liver transplantation based on etiology of liver disease. | 2013 | Details |
| A23939 | 23370355 | Biol Pharm Bull | A novel inhibitor of stearoyl-CoA desaturase-1 attenuates hepatic lipid accumulation, liver injury and inflammation in model of nonalcoholic steatohepatitis. | 2013 | Details |
| A23940 | 23369934 | Food Chem Toxicol | Anti-oxidant and natural killer cell activity of Korean red ginseng (Panax ginseng) and urushiol (Rhus vernicifera Stokes) on non-alcoholic fatty liver disease of rat. | 2013 | Details |
| A23941 | 23369196 | Clin Exp Pharmacol Physiol | Relationship between serum osteocalcin levels and non-alcoholic fatty liver disease in Chinese men. | 2013 | Details |
| A23943 | 23367495 | J Clin Res Pediatr Endocrinol | Association between insulin resistance and oxidative stress parameters in obese adolescents with non-alcoholic fatty liver disease. | 2013 | Details |
| A23944 | 23367494 | J Clin Res Pediatr Endocrinol | High-sensitivity C-reactive protein levels and metabolic disorders in obese and overweight children and adolescents. | 2013 | Details |
| A23945 | 23363254 | Endocr Regul | Association of nonalcoholic fatty liver disease (NAFLD) with urolithiasis. | 2013 | Details |
| A23946 | 23363012 | Ann N Y Acad Sci | Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals. | 2013 | Details |
| A23947 | 27785221 | Gastroenterology Res | Association Between Appendectomy and Fibrosis Progression in Nonalcoholic Fatty Liver Disease. | 2013 | Details |
| A23948 | 23359475 | Pharmacotherapy | Pharmacologic therapy for nonalcoholic fatty liver disease in adults. | 2013 | Details |
| A23949 | 23357341 | J Genet Genomics | Genetics of nonalcoholic Fatty liver disease: an overview. | 2012 | Details |
| A23950 | 23356584 | Liver Int | Heterogeneity of fibrosis patterns in non-alcoholic fatty liver disease supports the presence of multiple fibrogenic pathways. | 2013 | Details |
| A23951 | 23355916 | World J Hepatol | Surgically induced weight loss by gastric bypass improves non alcoholic fatty liver disease in morbid obese patients. | 2012 | Details |
| A23952 | 23355910 | World J Hepatol | Is nonalcoholic fatty liver disease the hepatic expression of the metabolic syndrome? | 2012 | Details |
| A23953 | 23355909 | World J Hepatol | Nonalcoholic fatty liver disease and the renin-angiotensin system: Implications for treatment. | 2012 | Details |
| A23954 | 23353867 | J Hepatol | Post-transcriptional activation of PPAR alpha by KLF6 in hepatic steatosis. | 2013 | Details |
| A23955 | 23353640 | Clin Gastroenterol Hepatol | External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study. | 2013 | Details |
| A23956 | 23352496 | J Diabetes Complications | Potential of incretin-based therapies for non-alcoholic fatty liver disease. | 2013 | Details |
| A23959 | 23351585 | J Clin Lipidol | Genetic determinants of cardiometabolic risk: a proposed model for phenotype association and interaction. | 2012 | Details |
| A23960 | 23348961 | Gut | Yin Yang 1 promotes hepatic steatosis through repression of farnesoid X receptor in obese mice. | 2013 | Details |
| A23961 | 23348573 | Hepatology | Thyroid hormone-responsive SPOT 14 homolog promotes hepatic lipogenesis, and its expression is regulated by liver X receptor α through a sterol regulatory element-binding protein 1c-dependent mechanism in mice. | 2013 | Details |
| A23962 | 23348005 | Toxicol In Vitro | Quercetin ameliorate insulin resistance and up-regulates cellular antioxidants during oleic acid induced hepatic steatosis in HepG2 cells. | 2013 | Details |
| A23963 | 23347840 | Clin Res Hepatol Gastroenterol | Non-alcoholic steatohepatitis in morbidly obese patients. | 2013 | Details |
| A23964 | 23347437 | Hepatol Res | Survey of non-B, non-C liver cirrhosis in Japan. | 2013 | Details |
| A23965 | 23346152 | Hepat Mon | First National Report on Aminotransaminases' Percentiles in Children of the Middle East and North Africa (MENA): the CASPIAN-III Study. | 2012 | Details |
| A23966 | 23346150 | Hepat Mon | Predictive factors for ultrasonographic grading of nonalcoholic Fatty liver disease. | 2012 | Details |
| A23967 | 23346097 | Front Genet | Molecular Interactions between NAFLD and Xenobiotic Metabolism. | 2013 | Details |
| A23968 | 23344895 | Pediatr Cardiol | Subclinical hypothyroidism as a risk factor for the development of cardiovascular disease in obese adolescents with nonalcoholic fatty liver disease. | 2013 | Details |
| A23969 | 23340336 | Br J Nutr | Carbohydrate quality is not associated with liver enzyme activity and plasma TAG and HDL concentrations over 5 years in an older population. | 2013 | Details |
| A23970 | 23339953 | J Hepatol | Pharmacological promotion of autophagy alleviates steatosis and injury in alcoholic and non-alcoholic fatty liver conditions in mice. | 2013 | Details |
| A23971 | 23337953 | Nat Rev Endocrinol | The role of hepatokines in metabolism. | 2013 | Details |
| A23972 | 23334462 | Diabetologia | Adipose tissue is inflamed in NAFLD due to obesity but not in NAFLD due to genetic variation in PNPLA3. | 2013 | Details |
| A23974 | 23333450 | J Hepatol | Essential fatty acids deficiency promotes lipogenic gene expression and hepatic steatosis through the liver X receptor. | 2013 | Details |
| A23975 | 23332087 | Hepatol Res | Liver and diabetes. A vicious circle. | 2013 | Details |
| A23976 | 23331460 | Basic Clin Pharmacol Toxicol | Quercetin decreases liver damage in mice with non-alcoholic steatohepatitis. | 2013 | Details |
| A23977 | 23330253 | Harefuah | [Challenges in liver diseases and transplantation]. | 2012 | Details |
| A23978 | 23329754 | J Pediatr Endocrinol Metab | A decrease in fasting FGF19 levels is associated with the development of non-alcoholic fatty liver disease in obese adolescents. | 2012 | Details |
| A23979 | 23329465 | Drugs | Nonalcoholic fatty liver disease: current issues and novel treatment approaches. | 2013 | Details |
| A23980 | 23329365 | J Gastroenterol | Increased hepatic oxidative DNA damage in patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma. | 2013 | Details |
| A23981 | 23329217 | Arq Gastroenterol | Risk factors for nonalcoholic steatohepatitis in cryptogenic cirrhosis. | 2012 | Details |
| A23982 | 23329013 | Dig Dis Sci | Fat mass and obesity-associated gene enhances oxidative stress and lipogenesis in nonalcoholic fatty liver disease. | 2013 | Details |
| A23983 | 23328905 | Curr Atheroscler Rep | Statins in nonalcoholic fatty liver disease and steatohepatitis: updated review. | 2013 | Details |
| A23984 | 23327974 | J Nutr Sci Vitaminol (Tokyo) | Effects of dietary supplementation with betaine on a nonalcoholic steatohepatitis (NASH) mouse model. | 2012 | Details |
| A23985 | 23326306 | PLoS One | Non-alcoholic fatty liver disease is closely associated with sub-clinical inflammation: a case-control study on Asian Indians in North India. | 2013 | Details |
| A23986 | 23326163 | World J Gastroenterol | Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification. | 2013 | Details |
| A23987 | 23325576 | Hepatology | Hepatic reticuloendothelial system cell iron deposition is associated with increased apoptosis in nonalcoholic fatty liver disease. | 2013 | Details |
| A23988 | 23325287 | Eur J Gastroenterol Hepatol | Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels? | 2013 | Details |
| A23989 | 23324907 | Herz | Increased H-FABP concentrations in nonalcoholic fatty liver disease. Possible marker for subclinical myocardial damage and subclinical atherosclerosis. | 2013 | Details |
| A23990 | 23320802 | Alcohol Clin Exp Res | Hepatic and extrahepatic malignancies in cirrhosis caused by nonalcoholic steatohepatitis and alcoholic liver disease. | 2013 | Details |
| A23991 | 23323254 | Clin Mol Hepatol | Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease. | 2012 | Details |
| A23994 | 23320150 | J Obes | Nonalcoholic fatty liver disease and cardiovascular disease: has the time come for cardiologists to be hepatologists? | 2012 | Details |
| A23995 | 23320041 | Evid Based Complement Alternat Med | Study of the effects of monacolin k and other constituents of red yeast rice on obesity, insulin-resistance, hyperlipidemia, and nonalcoholic steatohepatitis using a mouse model of metabolic syndrome. | 2012 | Details |
| A23996 | 23318274 | Biochim Biophys Acta | The human liver fatty acid binding protein (FABP1) gene is activated by FOXA1 and PPARα; and repressed by C/EBPα: Implications in FABP1 down-regulation in nonalcoholic fatty liver disease. | 2013 | Details |
| A23997 | 23317398 | Curr Pharm Des | Ezetimibe therapy for dyslipidemia: an update. | 2013 | Details |
| A23998 | 23316084 | J Clin Endocrinol Metab | Insulin-like growth factor-I, inflammatory proteins, and fibrosis in subjects with nonalcoholic fatty liver disease. | 2013 | Details |
| A23999 | 23315950 | Hepatology | Maternal obesity programs offspring nonalcoholic fatty liver disease by innate immune dysfunction in mice. | 2013 | Details |
| A24000 | 23315648 | Z Gastroenterol | Non-alcoholic steatohepatitis occurs in celiac disease and is associated with cellular stress. | 2013 | Details |
| A24001 | 23313470 | Prostaglandins Leukot Essent Fatty Acids | Lipidomics of hepatic lipogenesis inhibition by omega 3 fatty acids. | 2013 | Details |
| A24002 | 23313215 | J Proteomics | Changes in the hepatic mitochondrial and membrane proteome in mice fed a non-alcoholic steatohepatitis inducing diet. | 2013 | Details |
| A24003 | 23312215 | J Diabetes Complications | Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes. | 2013 | Details |
| A24004 | 23307045 | J Gastroenterol | Dental infection of Porphyromonas gingivalis exacerbates high fat diet-induced steatohepatitis in mice. | 2013 | Details |
| A24006 | 23305254 | Int J Exp Pathol | An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis. | 2013 | Details |
| A24007 | 23305008 | Klin Lab Diagn | [The unity of pathogenesis of insulin resistance syndrome and non-alcoholic fatty disease of liver. The metabolic disorder of fatty acids and triglycerides]. | 2012 | Details |
| A24008 | 23304532 | Int J Hepatol | Multidisciplinary pharmacotherapeutic options for nonalcoholic Fatty liver disease. | 2012 | Details |
| A24009 | 23304464 | J Obes | The relationship between nonalcoholic fatty liver disease and colorectal cancer: the future challenges and outcomes of the metabolic syndrome. | 2012 | Details |
| A24010 | 23304197 | Evid Based Complement Alternat Med | Effects of lipid regulation using raw and processed radix polygoni multiflori in rats fed a high-fat diet. | 2012 | Details |
| A24011 | 23303872 | J Nutr | Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis. | 2013 | Details |